Immatics Biotechnologies GmbH - Product Pipeline Review - 2016

Date: February 24, 2016
Pages: 46
Price:
US$ 1,500.00 US$ 1,275.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I95D7377ABCEN
Leaflet:

Download PDF Leaflet

Immatics Biotechnologies GmbH - Product Pipeline Review - 2016

SUMMARY

Global Markets Direct’s, ‘immatics biotechnologies GmbH - Product Pipeline Review - 2016’, provides an overview of the immatics biotechnologies GmbH’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by immatics biotechnologies GmbH, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

SCOPE
  • The report provides a snapshot of the pipeline therapeutic landscape of immatics biotechnologies GmbH
  • The report provides overview of immatics biotechnologies GmbH including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses immatics biotechnologies GmbH’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features immatics biotechnologies GmbH’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
REASONS TO BUY
  • Evaluate immatics biotechnologies GmbH’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for immatics biotechnologies GmbH
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding immatics biotechnologies GmbH’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Immatics Biotechnologies GmbH Snapshot
Immatics Biotechnologies GmbH Overview
Key Information
Key Facts
Immatics Biotechnologies GmbH - Research and Development Overview
Key Therapeutic Areas
Immatics Biotechnologies GmbH - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Immatics Biotechnologies GmbH - Pipeline Products Glance
Immatics Biotechnologies GmbH - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Immatics Biotechnologies GmbH - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Immatics Biotechnologies GmbH - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Immatics Biotechnologies GmbH - Drug Profiles
IMA-901
Product Description
Mechanism of Action
R&D Progress
IMA-910
Product Description
Mechanism of Action
R&D Progress
APVAC-1
Product Description
Mechanism of Action
R&D Progress
APVAC-2
Product Description
Mechanism of Action
R&D Progress
IMA-950
Product Description
Mechanism of Action
R&D Progress
IMA-101
Product Description
Mechanism of Action
R&D Progress
IMA-102
Product Description
Mechanism of Action
R&D Progress
IMA-201
Product Description
Mechanism of Action
R&D Progress
IMA-202
Product Description
Mechanism of Action
R&D Progress
IMA-203
Product Description
Mechanism of Action
R&D Progress
IMA-300
Product Description
Mechanism of Action
R&D Progress
IMA-301
Product Description
Mechanism of Action
R&D Progress
Recombinant Protein for Solid Tumors
Product Description
Mechanism of Action
R&D Progress
Immatics Biotechnologies GmbH - Pipeline Analysis
Immatics Biotechnologies GmbH - Pipeline Products by Target
Immatics Biotechnologies GmbH - Pipeline Products by Route of Administration
Immatics Biotechnologies GmbH - Pipeline Products by Molecule Type
Immatics Biotechnologies GmbH - Recent Pipeline Updates
Immatics Biotechnologies GmbH - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Immatics Biotechnologies GmbH, Key Information
Immatics Biotechnologies GmbH, Key Facts
Immatics Biotechnologies GmbH - Pipeline by Indication, 2016
Immatics Biotechnologies GmbH - Pipeline by Stage of Development, 2016
Immatics Biotechnologies GmbH - Monotherapy Products in Pipeline, 2016
Immatics Biotechnologies GmbH - Partnered Products in Pipeline, 2016
Immatics Biotechnologies GmbH - Partnered Products/ Combination Treatment Modalities, 2016
Immatics Biotechnologies GmbH - Out-Licensed Products in Pipeline, 2016
Immatics Biotechnologies GmbH - Out-Licensed Products/ Combination Treatment Modalities, 2016
Immatics Biotechnologies GmbH - Phase III, 2016
Immatics Biotechnologies GmbH - Phase II, 2016
Immatics Biotechnologies GmbH - Phase I, 2016
Immatics Biotechnologies GmbH - Preclinical, 2016
Immatics Biotechnologies GmbH - Discovery, 2016
Immatics Biotechnologies GmbH - Pipeline by Target, 2016
Immatics Biotechnologies GmbH - Pipeline by Route of Administration, 2016
Immatics Biotechnologies GmbH - Pipeline by Molecule Type, 2016
Immatics Biotechnologies GmbH - Recent Pipeline Updates, 2016
Immatics Biotechnologies GmbH, Subsidiaries

LIST OF FIGURES

Immatics Biotechnologies GmbH - Pipeline by Indication, 2016
Immatics Biotechnologies GmbH - Pipeline by Stage of Development, 2016
Immatics Biotechnologies GmbH - Monotherapy Products in Pipeline, 2016
Immatics Biotechnologies GmbH - Pipeline by Route of Administration, 2016
Immatics Biotechnologies GmbH - Pipeline by Molecule Type, 2016
Skip to top


Ask Your Question

Immatics Biotechnologies GmbH - Product Pipeline Review - 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: